Identity
HGNC
LOCATION
14q21.1
LOCUSID
ALIAS
C14orf146,FIGLER8,SALM5
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 145581
MIM: 612811
HGNC: 20360
Ensembl: ENSG00000165379
Variants:
dbSNP: 145581
ClinVar: 145581
TCGA: ENSG00000165379
COSMIC: LRFN5
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000165379 | ENST00000298119 | Q96NI6 |
| ENSG00000165379 | ENST00000554120 | G3V4N1 |
| ENSG00000165379 | ENST00000554171 | G3V364 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37280213 | 2023 | LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study. | 3 |
| 37280213 | 2023 | LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study. | 3 |
| 35088940 | 2022 | LRFN5 locus structure is associated with autism and influenced by the sex of the individual and locus conversions. | 5 |
| 36266731 | 2022 | CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. | 35 |
| 35088940 | 2022 | LRFN5 locus structure is associated with autism and influenced by the sex of the individual and locus conversions. | 5 |
| 36266731 | 2022 | CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. | 35 |
| 31152157 | 2019 | Microdeletion of pseudogene chr14.232.a affects LRFN5 expression in cells of a patient with autism spectrum disorder. | 9 |
| 31748543 | 2019 | Identification of novel common variants associated with chronic pain using conditional false discovery rate analysis with major depressive disorder and assessment of pleiotropic effects of LRFN5. | 11 |
| 31152157 | 2019 | Microdeletion of pseudogene chr14.232.a affects LRFN5 expression in cells of a patient with autism spectrum disorder. | 9 |
| 31748543 | 2019 | Identification of novel common variants associated with chronic pain using conditional false discovery rate analysis with major depressive disorder and assessment of pleiotropic effects of LRFN5. | 11 |
| 29348429 | 2018 | Structural basis of trans-synaptic interactions between PTPδ and SALMs for inducing synapse formation. | 22 |
| 29348579 | 2018 | Structural basis of SALM5-induced PTPδ dimerization for synaptic differentiation. | 28 |
| 29348429 | 2018 | Structural basis of trans-synaptic interactions between PTPδ and SALMs for inducing synapse formation. | 22 |
| 29348579 | 2018 | Structural basis of SALM5-induced PTPδ dimerization for synaptic differentiation. | 28 |
| 21736948 | 2011 | The SALM/Lrfn family of leucine-rich repeat-containing cell adhesion molecules. | 35 |
Citation
Dessen P
LRFN5 (leucine rich repeat and fibronectin type III domain containing 5)
Atlas Genet Cytogenet Oncol Haematol. 2014-11-01
Online version: http://atlasgeneticsoncology.org/gene/68580/lrfn5-(leucine-rich-repeat-and-fibronectin-type-iii-domain-containing-5)
